Covered recipient · General Payments record
RUSSELL P GOLLARD
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$113,934.29
- Reported across 791 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,249.57 | 19 |
| Honoraria | $1,000.00 | 1 |
| Education | $430.15 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Avyxa Pharma, LLC | $1,000.00 | 1 |
| SOBI, INC | $366.50 | 3 |
| Lilly USA, LLC | $323.93 | 2 |
| Daiichi Sankyo Inc. | $235.65 | 5 |
| GENZYME CORPORATION | $161.94 | 2 |
| Penumbra, Inc. | $143.04 | 1 |
| Janssen Biotech, Inc. | $119.08 | 2 |
| Novocure Inc. | $83.82 | 1 |
| ABBVIE INC. | $80.21 | 1 |
| Gilead Sciences, Inc. | $75.04 | 2 |
| EMD Serono, Inc. | $31.37 | 1 |
| Janssen Pharmaceuticals, Inc | $25.72 | 1 |
| Regeneron Healthcare Solutions, Inc. | $18.70 | 1 |
| Karyopharm Therapeutics Inc. | $14.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $80.21 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103813812 | CMS |
| Avyxa Pharma, LLC | $1,000.00 | 12/19/2024 | Honoraria | Undisputed | 01/23/2026 | 1130788751 | CMS |
| Daiichi Sankyo Inc. | $119.97 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089426877 | CMS |
| Daiichi Sankyo Inc. | $12.75 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089426879 | CMS |
| Daiichi Sankyo Inc. | $13.47 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089426881 | CMS |
| Daiichi Sankyo Inc. | $14.45 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089426873 | CMS |
| Daiichi Sankyo Inc. | $75.01 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089426875 | CMS |
| EMD Serono, Inc. | $31.37 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120274654 | CMS |
| GENZYME CORPORATION | $40.07 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139623385 | CMS |
| GENZYME CORPORATION | $121.87 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139623377 | CMS |
| Gilead Sciences, Inc. | $45.84 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133804473 | CMS |
| Gilead Sciences, Inc. | $29.20 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133804475 | CMS |
| Janssen Biotech, Inc. | $89.95 | 05/29/2024 | Education | Undisputed | 01/23/2026 | 1078388188 | CMS |
| Janssen Biotech, Inc. | $29.13 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078388063 | CMS |
| Janssen Pharmaceuticals, Inc | $25.72 | 08/28/2024 | Education | Undisputed | 01/23/2026 | 1078099058 | CMS |
| Karyopharm Therapeutics Inc. | $14.72 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145536432 | CMS |
| Lilly USA, LLC | $109.44 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135367776 | CMS |
| Lilly USA, LLC | $214.49 | 11/03/2024 | Education | Undisputed | 01/23/2026 | 1135378118 | CMS |
| Novocure Inc. | $83.82 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123338503 | CMS |
| Penumbra, Inc. | $143.04 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1076219068 | CMS |
| Regeneron Healthcare Solutions, Inc. | $18.70 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114057584 | CMS |
| SOBI, INC | $130.06 | 10/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141430497 | CMS |
| SOBI, INC | $136.45 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141427253 | CMS |
| SOBI, INC | $99.99 | 12/23/2024 | Education | Undisputed | 01/23/2026 | 1141427733 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.